Possible involvement of stress-activated protein kinase signaling pathway and fas receptor expression in prevention of ischemia/reperfusion- induced cardiomyocyte apoptosis by carvedilol

Circulation Research

Volumn 82, Issue 2, 1998, Pages 166-174

  Yue, Tian Li ^b   Ma, Xin Liang ^a   Wang, Xinkang ^c   Romanic, Anne M ^c   Liu, Gao Lin ^a   Louden, Calvert ^c   Gu, Juan Li ^c   Kumar, Sanjay ^c   Poste, George ^c   Ruffolo Jr , Robert R ^c   Feuerstein, Giora Z ^c  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b GLAXOSMITHKLINE   (United Kingdom)

^c NONE

Author keywords

Apoptosis; Cardiomyocyte; Fas; Ischemia; Reperfusion; Stress activated protein kinase

Indexed keywords

CARVEDILOL; PROPRANOLOL; PROTEIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BETA ADRENERGIC STIMULATION; DRUG EFFECT; ENZYME ACTIVATION; ENZYME INHIBITION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RABBIT; REPERFUSION INJURY; SIGNAL TRANSDUCTION; STRESS; VASODILATATION;

EID: 0032498614     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.82.2.166     Document Type: Article

References (41)

1. Wolfe JT, Pringle JH, Cohen GM. Assays for the measurement of DNA fragmentation during apoptosis. In: Cotter TG, Martin SJ, eds. Techniques in Apoptosis. London, England: Portland Press; 1966:51-69.
2. Tanaka M, Ito H, Adachi S, Akimoto H, Nishikawa T, Kasajima T, Marumo F, Hiroe M. Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ Res. 1994;75:426-433.
3. Umansky SR, Cueno GM, Khutzian SS, Barr PJ, Tomei DL. Post-ischemic apoptotic death of rat neonatal cardiomyocytes. Cell Death Differ. 1995;2:236-241.
4. Cheng W, Li B, Kajstura J, Li P, Wolin MS, Sonnenhick EH, Hintze TH. Stretch-induced programmed myocyte cell death. J Clin Invest. 1995;96:2247-2259.
5. Gottlieb RA, Burleson KO, Kloner RA, Babior BM, Engler RL. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest. 1994;94:1621-1628.
6. Fliss H, Gattinger D. Apoptosis in ischemic and reperfused rat myocardium. Circ Res. 1996;79:949-956.
7. Buerke M, Murohara T, Skurk C, Nuss C, Tomaselli K, Lefer AM. Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion. Proc Natl Acad Sci U S A. 1995;92:8031-8035.
8. Narula J, Haider N, Virmani R, Disalvo TG, Kolodgie FD, Hajjar RJ, Schmidt U, Semigran MJ, Dec GW, Khaw B-A. Apoptosis in myocytes in end-stage heart failure. N Engl J Med. 1996;335:1182-1189.
9. Mallat Z, Tedgui A, Fontaliran F, Frank R, Durigon M, Fontaine G. Evidence of apoptosis in arrhythmogenic right ventricular dysplasia. N Engl J Med. 1996;335:1190-1196.
10. Olivetti G, Quaini F, Sala R, Lagrasta C, Corradi D, Bonacina E, Gambert SR, Cigola E, Anversa P. Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart. J Mol Cell Cardiol. 1994;28:2005-2016.
11. Colucci WS. Apoptosis in the heart. N Engl J Med. 1996;335:1224-1226.
12. Yeh ETH. Life and death in the cardiovascular system. Circulation. 1997;95:782-786.
13. Ruffolo RR, Boyle D, Venuit RP, Lukas M. Carvedilol (Kredex): a novel multiple action cardiovascular agent. Drugs Today. 1991;27:465-492.
14. Yue TL, Cheng HY, Lysko PG, McKenna PJ, Feuerstein R, Gu JL, Lysko KA, Davis LL, Feuerstein GZ. Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger. J Pharmacol Exp Ther. 1992;263:92-98.
15. Feuerstein GZ, George P, Ruffolo RR. Carvedilol update, III: rational for use in congestive heart failure. Drugs Today. 1995;31:307-326.
16. Packer M, Dristow MR, Cohn JN, Colucci WS, Fowler MB, Gilber EM, Shusterman NH. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. New Engl J Med. 1996;334:1349-1397.
17. Nagata S, Golstein P. The Fas death factor. Science. 1995;267:1449-1456.
18. Reed JC, Miyashita T, Takayama S, Wang HG, Sato S, Krajewski C, Aime-Sempe S, Bodrug S, Kitada S, Hanada M. Bcl-2 family proteins: regulators of cell death involved in the pathogenesis of cancer and resistance to therapy. J Cell Biochem. 1996;60:23-32.
19. Hibi M, Lin A, Smeal T, Minden A, Karin M. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev. 1993;7:2135-2148.
20. Kyriakis JM, Banerjee P, Nikolakaki E. The stress-activated protein kinase subfamily of c-jun kinase. Nature. 1994;369:156-160.
21. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. Opposing effects of ERK and JNK-38 MAP kinases on apoptosis. Science. 1995;270:1326-1331.
22. Ma XL, Yue TL, Lopez BL, Barone FC, Christopher TA, Ruffolo RR Jr, Feuerstein GZ. Carvedilol, a new beta adrenoreceptor blocker and free radical scavenger, attenuates myocardial ischemia-reperfusion injury in hypercholesterolemic rabbits. J Pharmacol Exp Ther. 1996;277:128-136.
23. Yue TL, Wang XK, Louden CS, Gupta S, Pillarisetti K, Gu JL, Hart TK, Lysko PG, Feuerstein GZ. 2-Methoxyestradiol, an endogenous estrogen metabolite, induces apoptosis in endothelial cells and inhibits angiogenesis: possible role for stress-activated protein kinase signaling pathway and Fas expression. Mol Pharmacol. 1997;51:951-962.
24. Bogoyevitch MA, Gillespie-Brown J, Ketterman AJ, Fuller SJ, Ben-Levy R, Ashworth A, Marshall CJ, Sugden PH. Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart: p38/RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion. Circ Res. 1996;79:162-173.
25. Verheij M, Bose R, Lin XH, Yao B, Jarvis WD, Gram S, Birrer MJ, Szabo E, Zon LI, Kyriakis JM, Haimovitz-Friedman A, Fuks Z, Kolesnick RN. Requirement for ceramide-initiated SAPK/JUK signaling in stress-induced apoptosis. Nature. 1996;380:75-79.
26. Anversa P, Kajstura J, Olivetti G. Myocyte death in heart failure. Curr Opin Cardiol. 1996;11:245-251.
27. Feuerstein ZG, Ruffolo RR Jr, Yue TL. Apoptosis and congestive heart failure. Trends Cardiovasc Med. 1997;7:249-255.
28. Krown KA, Page MT, Nguyen C, Zechner D, Gutierrez V, Comstock KL, Glembotski CC, Quintana PJE, Sabbadini RA. Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. J Clin Invest. 1996;98:2854-2865.
29. Kajstura J, Cheng W, Reiss K, Clark WA, Sonneblick EH, Krajewski S, Reed JC, Olivetti G, Anversa P. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest. 1996;74:86-107.
30. Ohno M, Misao J, Hayakawa Y, Takemura G, Kato S, Kano M, Minatoguchi S, Fujiwara T, Fujiwara H. Expression of Bcl-2, an inhibitor of apoptosis, in rabbit hearts with myocardial infarction. Circulation. 1996;94(suppl I):I-226. Abstract.
31. McConkey DJ, Orrenius S. Signal transduction pathways in apoptosis. Stem Cells. 1996;14:619-631.
32. Kubler W, Strasser RH. Signal transduction in myocardial ischemia. Eur Heart J. 1994;15:437-445.
33. Force T, Pombo CM, Avruch JA, Bonventre JV, Kyriakis JM. Stress-activated protein kinases in cardiovascular disease. Circ Res. 1996;78:947-953.
34. Maggi E, Marchesi E, Covini D, Negro C, Perani G, Bellomo G. Protective effects of carvedilol, a vasodilating β-adrenoceptor blocker, against in vivo low density lipoprotein oxidation in essential hypertension. J Cardiovosc Pharmacol 1996;27:532-538.
35. Buttke TM, Sandstrom PA. Oxidative stress as a mediator of apoptosis. Immunol Today. 1994;15:7-10.
36. Zhong LT, Sarafian R, Kane DJ, Charles AC, Mah SP, Edwards RH, Bredesen DE. bcl-2 inhibits death of central neural cells induced by multiple agents. Proc Natl Acad Sci U S A. 1993;90:4533-4537.
37. Ramakrishnan N. Catravas GN. N-(2-Mercaptoethyl)-1,3-propanediamine (WR-1065) proteco thymocytes from programmed cell death. J Immmol. 1992;149:3302-3308.
38. Hirose K, Longo DL, Oppenheim JJ, Marsushima K. Overexpression of mitochondrial manganese superoxide dismutase promotes the survival of tumor cells exposed to interleukin-1, tumor necrosis factor, selected anticancer drugs, and ionizing radiation. FASEB J. 1994;7:361-368.
39. Devary Y, Gottlieb R, Smeal T, Karin M. The mammalian ultraviolet response is triggered by activation of Src tyrosine kinase. Cell. 1992;71:1081-1091.
40. Laderoute KR, Webster KA. Hypoxia/reoxygenation stimulates Jun kinase activity through redox signaling in cardiac myocytes. Circ Res. 1997;80:336-344.
41. Yin T, Sandhu G, Wolfgang CD, Burrier A, Webb RL, Rigel DF, Hai T, Wheian J. Tissue-specific pattern of stress kinase activation in ischemic/reperfused heart and kidney. J Biol Chem. 1997;272:19943-19950.